American Journal of Kidney Diseases
Volume 52, Issue 5 , Pages 834-838 , November 2008

More Than Reducing Early Fistula Thrombosis Is Required: Lessons From the Dialysis Access Consortium Clopidogrel Fistula Study

  • Charmaine E. Lok, MD

      Affiliations

    • Toronto General Hospital, University of Toronto, Toronto, Canada
    • Corresponding Author InformationAddress correspondence to Charmaine E. Lok, MD, Department of Medicine, Division of Nephrology, The Toronto General Hospital, 8NU-844, 200 Elizabeth St, Toronto, Ontario M5G 2C4, Canada
    • ,
  • Louise Moist, MD

      Affiliations

    • London Health Sciences Center, University of Western Ontario, London, Canada

References 

  1. Clinical Performance Measures (CPM) Project: Phase III ESRD CPM 04012008 Final. http://www.cms.hhs.gov/CPMProject/Downloads/ESRDPhaseIIICPM04012008Final.pdfAccessed June 1, 2008
  2. Moist LM, Chang SH, Polkinghorne KR, McDonald SP. Trends in hemodialysis vascular access from the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) 2000 to 2005. Am J Kidney Dis. 2007;50:612–621
  3. Moist LM, Trpeski L, Na Y, Lok CE: Increased hemodialysis catheter use in Canada and associated mortality risk: data from the Canadian Organ Replacement Registry 2001-2004. Clin J Am Soc Nephrol 2008 (in press)
  4. US Renal Data System. USRDS 2006 Annual Data Report: Atlas of endstage renal disease in the United States (In Costs of CKD and ESRD: Vascular Access). Betheseda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2006;
  5. Lok CE. Fistula first initiative: advantages and pitfalls. Clin J Am Soc Nephrol. 2007;2:1043–1053
  6. Lacson E, Lazarus JM, Himmelfarb J, et al. Balancing Fistula First with Catheters Last. Am J Kidney Dis. 2007;50:379–395
  7. Lok CE, Allon M, Moist L, et al. Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I). J Am Soc Nephrol. 2006;17:3204–3212
  8. Dember LM, Beck GJ, Allon M, et al. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA. 2008;299:2164–2171
  9. Andrassy K, Malluche H, Bornefeld H, et al. Prevention of p.o. clotting of av. cimino fistulae with acetylsalicyl acid (Results of a prospective double blind study). Klin Wochenschr. 1974;52:348–349
  10. Michie D, Wombolt D. Use of sulfinpyrazone to prevent thrombus formation in arteriovenous fistulas and bovine grafts of patients on chronic hemodialysis. Curr Ther Res. 1977;22:196–204
  11. Albert E. Prevention of early thrombus formation in arteriovenous fistulae. Dial Transplant. 1981;10:167C–167D
  12. Grontoft KC, Mulec H, Gutierrez A, Olander R. Thromboprophylactic effect of ticlopidine in arteriovenous fistulas for haemodialysis. Scand J Urol Nephrol. 1985;9:55–57
  13. Fiskerstrand CE, Thompson IW, Burnet ME, et al. Double-blind randomized trial of the effect of ticlopidine in arteriovenous fistulas for hemodialysis. Artif Organs. 1985;9:61–63
  14. Janicki K, Dmoszynska A, Janicka L, et al. Influence of antiplatelet drugs on occlusion of arteriovenous fistula in uraemic patients. Int Urol Nephrol. 1992;24:83–89
  15. Janicki K, Janicka L, Dmoszynska A, Marczewski K, Smarz I. Effects of ticoplidine on platelet activity and occlusion of arteriovenous fistulas in IPD patients. Dial Transplant. 1994;23:576–579
  16. Grontoft KC, Larsson R, Mulec H, et al. Effects of ticlopidine in AV-fistula surgery in uremia (Fistula Study Group). Scand J Urol Nephrol. 1998;32:276–283
  17. Dember LM, Kaufman JS, Beck GJ, et al. Design of the Dialysis Access Consortium (DAC) Clopidogrel Prevention of Early AV Fistula Thrombosis Trial. Clin Trials. 2005;2:413–422
  18. Ashley I: Personal communication, July 2008. FAVOURED Trial: Fish oil and aspirin in vascular access outcomes in renal disease
  19. Hasegawa T, Elder SJ, Bragg-Gresham JL, et al. Consistent aspirin use associated with improved arteriovenous fistula survival among incident hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Clin J Am Soc Nephrol. 2008;3:1373–1378
  20. Peterson WJ, Barker J, Allon M. Disparities in fistula maturation persist despite preoperative vascular mapping. Clin J Am Soc Nephrol. 2008;3:437–441
  21. Korten E, Toonder IM, Schrama YC, et al. Dialysis fistulae patency and preoperative diameter ultrasound measurements. Eur J Vasc Endovasc Surg. 2007;33:467–471
  22. Huber TS, Ozaki CK, Flynn TC, et al. Prospective validation of an algorithm to maximize native arteriovenous fistulae for chronic hemodialysis access. J Vasc Surg. 2002;36:452–459
  23. Falk A. Maintenance and salvage of arteriovenous fistulas. J Vasc Interv Radiol. 2006;17:807–813
  24. Rooijens PP, Burgmans JP, Yo TI, et al. Autogenous radial-cephalic or prosthetic brachial-antecubital forearm loop AVF in patients with compromised vessels? (A randomized, multicenter study of the patency of primary hemodialysis access). J Vasc Surg. 2005;42:481–486
  25. Biuckians A, Scott EC, Meier GH, et al. The natural history of autologous fistulas as first-time dialysis access in the KDOQI era. J Vasc Surg. 2008;47:415–421
  26. Slayden GC, Spergel L, Jennings WC: Secondary arteriovenous fistulas; converting prosthetic AV grafts to autogenous dialysis access. Semin Dial 2008 (in press)
  27. Vascular Access 2006 Work Group: Clinical practice guidelines for vascular access. Am J Kidney Dis. 2006;48:S176–S247
  28. Polkinghorne KR, Lau KK, Saunder A, et al. Does monthly native arteriovenous fistula blood-flow surveillance detect significant stenosis—a randomized controlled trial. Nephrol Dial Transplant. 2006;21:2498–2506
  29. Moist LM, Churchill DN, House AA, et al. Regular monitoring of access flow compared with monitoring of venous pressure fails to improve graft survival. J Am Soc Nephrol. 2003;14:2645–2653

PII: S0272-6386(08)01355-3

doi: 10.1053/j.ajkd.2008.09.005

American Journal of Kidney Diseases
Volume 52, Issue 5 , Pages 834-838 , November 2008

Article Tools